Skip to main content
High RiskFDAfda-F-0005-2016UNDECLARED ALLERGEN

Caribou Chocolate Chip Toffee Pecan Biscotti, Net Wt. 1.4 oz. (40g) in clear cello flow wrap bag.

Units Affected
6,166
Recall Date
August 6, 2015
Issuing Agency
Hazard
Undeclared Allergen

FDA Recall Notice

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-0005-2016.

Biscotti Almond and Biscotti Chocolate Chip Toffee Pecan are being recalled because they are labeled inadequately. Soy lecithin, a sub-ingredient, was missing from the ingredient list.

Corrective Action (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-0005-2016.

Recall terminated by FDA.

✅ What you should do

  1. Stop using the product if you own it.
  2. Check the model number, lot code, or sell-by date against the recall notice above.
  3. Contact Caribou Coffee Company Inc. or the retailer where you bought it for a refund, replacement, or repair.
  4. For the most current official instructions, visit the FDA recall page.
  5. If you've been hurt by this product, report the incident to FDA.

Consumer Contact (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-0005-2016.

Caribou Coffee Company Inc.

FDA

About the U.S. Food and Drug Administration

The FDA regulates drugs, medical devices, food, cosmetics, and tobacco. Adverse event reports and recall notices are the main public safety signal.

Visit FDA.gov →

📣 Report a food, supplement, or cosmetic problem to the FDA

If you had a reaction, found contamination, or experienced a labeling problem with this product, report it to the FDA. The agency uses consumer reports to track emerging safety signals and trigger recalls.

How to report to FDAFile a report at FDA

Caribou Coffee Company Inc. Recall FAQ

Caribou Coffee Company Inc. is the subject of a snacks & candy safety report: Caribou Chocolate Chip Toffee Pecan Biscotti, Net Wt. 1.4 oz. (40g) in clear cello flow wrap bag.. The notice was published on August 6, 2015 by the U.S. Food and Drug Administration (FDA). Approximately 6,166 units are potentially affected.